U.S. markets closed

Becton, Dickinson and Company (BDX)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
241.09-1.29 (-0.53%)
At close: 4:00PM EDT

241.60 +0.51 (0.21%)
After hours: 4:37PM EDT

Sign in to post a message.
  • G
    GammaRayStunks
    This stock should be trading back above 260 270 based on earnings and the spinoff should be worth somewhere between 35 to 50. I will be a buyer all day at these levels. Keep selling boys
    Bullish
  • C
    Charles
    Good earnings report, trading below lower Bollinger band, going ex dividend in less than a month.

    I kind of want to go all-in tomorrow morning.
    Bullish
  • t
    ted
    Just wanted to make sure... y'all understand BDX makes majority of the syringes in the U.S. and supply most of the vaccine (100' of millions) injection purposes, right? Did y'all also realize that the cost of syringe has been climibing up rapidly since early 2020? The latest quarter earning will EXPLODE. Let's hold and all be +20%+++++ on the next earning report.
  • b
    bill
    #$%$ is it this co cannot do ANYTHING to please the market?Every earnings I hear they BEAT but go down anyway>Can somebody sell me a vowel???
  • J
    Jordan
    BDX will report a surprise earnings...
    Bullish
  • G
    GammaRayStunks
    Anyone here any thing on earnings whispers. Should be blow out qtr. Like last time. We were right here 259 after earnings should have broke out. Maybe this time it will release 275 285
  • M
    M
    I have held this stock for quite a while. It’s has not appreciated much since I added it to my portfolio. But I know from past history whenever I sell the stick goes up. Also whenever I buy the stock goes down.
  • A
    Anonymous
    Anyone got any intel?
    Neutral
  • S
    StevenS
    going to 275 easy
  • r
    robert
    BDX is cheap at these levels. Holding for the long haul,
    Bullish
  • R
    Rajeesh
    Expecting a strong ⬆️movement in BD and rest of healthcare stocks followed by J&J approval. Fingers crossed 🤞
    Bullish
  • V
    Value Speculator
    If their Coronavirus virus test for present and past virus is real and can be mass market produced quickly, it will be a game changer.
  • E
    EandC
    I seriously think BD should stop being a Covid testing business. So far, they have been having a lot of challenges in that department. Besides, there are plenty of companies out there who have better tests. Although Covid tests are a very small portion of BD’s revenue (and profitability), any bad news regarding its Covid tests results in a tenfold negative impact on its shares. I think BD should just focus on its legacy business/products, and any Covid windfall (and its only temporary anyway!) will come from its vaccine delivery products. Stock price down $8/9 because some of its tests are having false readings? Well, even if BD loses all its revenue from the testing equipment, the bottom line will not change much. As for its other legacy business, we know it will come back in the next year. So I think this is a really good price point to get in – again, this is not a short term play; if you can hold on to this stock for 6 months and beyond, I am pretty confident it will go back to the $260 - $270 range within a year.
  • N
    NetDoggyDog
    Why does BDX not acquire or "lease" newer syringe technology from Retractable Technologies (RVP)? What is the litigation history between these two syringe producers? For half the $1.2B BDX is investing in their worldwide production, they could take out RVP. What am I missing?
  • D
    Darth
    What a great acquisition for BDX, they will make AKER a profitable company !
  • M
    Michael
    This stock needs to split to attract more millennial investors.
  • G
    GammaRayStunks
    Wowowow. Guidance was the real deal. no more being range bound, will break out. The hedgies have been like clock work in and out 220 to 250. Was easy for them. A close over 270 and some upgrades I think we could easily see 320 to 350 this year. And we getting a nice little Divy. Cant beat it. This stock not going to get pounded down anymore. The wearable injectable they own the space. Next two years of syringes being in short supply. Its almost to easy. Diabetic market to expand 20% to 30% next 5 years.
  • A
    Anonymous
    BDX product demand will increase even more as hospitals open up for other non-virus health care items.
  • J
    Jamie
    Can someone tell me why BDX is going down in price, is it because of high operating expenses, in other words why are people selling, lost $15.00 in three days, April 17, 2018
  • R
    Ricardo
    FDA warning regarding probable long term mortality caution on Bards coated balloons.